Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Arcus Biosciences, Inc. RCUS

Full chart Compare
Set alert

Price alert · RCUS

All alert types
17.69 USD -1.62 (-8.39%)

At closeNov 5, 2026, 4:51 PM EST

17.20 -0.49 -2.77%

After hours · Nov 5, 4:51 PM ET

17.50 Day range 19.42
17.69 52-week range 31.57
YTD
-25.77%
1 year
-10.43%

Financial health

Altman Z-Score

-1.13 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 1

Valuation

P/E -7.2×
FY 2016: -23.3×FY 2017: -7.9×FY 2018: -7.5×FY 2019: -5.2×FY 2020: -11.6×FY 2021: 53.3×FY 2022: -5.6×FY 2023: -4.6×FY 2024: -4.7×FY 2025: -7.2×
FY 2016 5y median -4.7× FY 2025
P/S 10.4×
FY 2016: 0.0×FY 2017: 295×FY 2018: 44.6×FY 2019: 29.5×FY 2020: 18.2×FY 2021: 7.3×FY 2022: 13.3×FY 2023: 12.1×FY 2024: 5.2×FY 2025: 10.4×
FY 2016 5y median 10.4× FY 2025
P/B 4.1×
FY 2016: 4.2×FY 2017: 2.7×FY 2018: 1.6×FY 2019: 2.7×FY 2020: 2.8×FY 2021: 3.3×FY 2022: 2.3×FY 2023: 3.1×FY 2024: 2.8×FY 2025: 4.1×
FY 2016 5y median 3.1× FY 2025
P/FCF -5.3×
FY 2016: -24.5×FY 2017: -13.7×FY 2018: -8.0×FY 2019: -5.9×FY 2020: 13.2×FY 2021: -9.9×FY 2022: 3.4×FY 2023: -4.3×FY 2024: -7.6×FY 2025: -5.3×
FY 2016 5y median -5.3× FY 2025
EV/EBITDA -7.3×
FY 2016: -20.9×FY 2017: -6.3×FY 2018: -5.9×FY 2019: -4.7×FY 2020: -10.6×FY 2021: 47.1×FY 2022: -5.4×FY 2023: -4.5×FY 2024: -4.7×FY 2025: -7.3×
FY 2016 5y median -4.7× FY 2025
EV/Sales 9.9×
FY 2016: 0.0×FY 2017: 226×FY 2018: 36.1×FY 2019: 25.6×FY 2020: 16.2×FY 2021: 7.3×FY 2022: 12.5×FY 2023: 11.1×FY 2024: 4.9×FY 2025: 9.9×
FY 2016 5y median 9.9× FY 2025
FCF Yield -18.9%
FY 2016: -4.1%FY 2017: -7.3%FY 2018: -12.5%FY 2019: -17.0%FY 2020: 7.6%FY 2021: -10.1%FY 2022: 29.0%FY 2023: -23.3%FY 2024: -13.1%FY 2025: -18.9%
FY 2016 5y median -13.1% FY 2025

Profitability

Gross Margin 96.0%
FY 2016: 0.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 96.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -156.3%
FY 2016: 0.0%FY 2017: -3782.1%FY 2018: -656.8%FY 2019: -591.4%FY 2020: -159.0%FY 2021: 14.1%FY 2022: -250.0%FY 2023: -290.6%FY 2024: -127.9%FY 2025: -156.3%
FY 2016 5y median -156.3% FY 2025
Net Margin -142.9%
FY 2016: 0.0%FY 2017: -3756.7%FY 2018: -593.7%FY 2019: -564.7%FY 2020: -157.7%FY 2021: 13.8%FY 2022: -238.4%FY 2023: -262.4%FY 2024: -109.7%FY 2025: -142.9%
FY 2016 5y median -142.9% FY 2025
ROE -55.9%
FY 2016: -18.1%FY 2017: -34.5%FY 2018: -21.1%FY 2019: -51.7%FY 2020: -24.5%FY 2021: 6.3%FY 2022: -40.6%FY 2023: -66.5%FY 2024: -58.4%FY 2025: -55.9%
FY 2016 5y median -55.9% FY 2025
ROIC -41.9%
FY 2016: -17.5%FY 2017: -30.1%FY 2018: -21.3%FY 2019: -49.2%FY 2020: -19.0%FY 2021: 3.6%FY 2022: -24.2%FY 2023: -36.9%FY 2024: -35.3%FY 2025: -41.9%
FY 2016 5y median -35.3% FY 2025
ROA -31.0%
FY 2016: -16.4%FY 2017: -27.9%FY 2018: -18.0%FY 2019: -41.7%FY 2020: -15.9%FY 2021: 3.3%FY 2022: -19.9%FY 2023: -28.0%FY 2024: -24.6%FY 2025: -31.0%
FY 2016 5y median -24.6% FY 2025

Growth (YoY)

Revenue -4.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 491.2%FY 2019: 79.6%FY 2020: 420.0%FY 2021: 391.0%FY 2022: -70.8%FY 2023: 4.5%FY 2024: 120.5%FY 2025: -4.3%
FY 2016 FY 2025
Operating Income -17.0%
FY 2016: 0.0%FY 2017: -193.9%FY 2018: -2.7%FY 2019: -61.7%FY 2020: -39.8%FY 2021: 143.5%FY 2022: -618.5%FY 2023: -21.4%FY 2024: 2.9%FY 2025: -17.0%
FY 2016 FY 2025
EPS (diluted) -4.8%
FY 2016: 0.0%FY 2017: -195.9%FY 2018: 33.8%FY 2019: -35.0%FY 2020: -16.1%FY 2021: 131.7%FY 2022: -622.5%FY 2023: -11.9%FY 2024: 24.3%FY 2025: -4.8%
FY 2016 FY 2025
Free Cash Flow -175.0%
FY 2016: 0.0%FY 2017: -79.4%FY 2018: -52.9%FY 2019: -61.3%FY 2020: 243.4%FY 2021: -361.1%FY 2022: 253.1%FY 2023: -176.4%FY 2024: 46.7%FY 2025: -175.0%
FY 2016 FY 2025

Financial Health

Current Ratio 4.4×
FY 2016: 18.0×FY 2017: 13.9×FY 2018: 15.3×FY 2019: 8.5×FY 2020: 6.0×FY 2021: 7.6×FY 2022: 5.5×FY 2023: 4.5×FY 2024: 4.5×FY 2025: 4.4×
FY 2016 5y median 4.5× FY 2025
Quick Ratio 4.4×
FY 2016: 18.0×FY 2017: 13.9×FY 2018: 15.3×FY 2019: 8.5×FY 2020: 6.0×FY 2021: 7.6×FY 2022: 5.5×FY 2023: 4.5×FY 2024: 4.5×FY 2025: 4.4×
FY 2016 5y median 4.5× FY 2025
Debt / Equity 0.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.2×FY 2023: 0.0×FY 2024: 0.1×FY 2025: 0.2×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 0.3×
FY 2016: 3.9×FY 2017: 1.9×FY 2018: 1.4×FY 2019: 0.7×FY 2020: 1.3×FY 2021: -0.4×FY 2022: 0.3×FY 2023: 0.4×FY 2024: 0.3×FY 2025: 0.3×
FY 2016 5y median 0.3× FY 2025
Interest Coverage -48.3×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -140×FY 2023: -170×FY 2024: -82.5×FY 2025: -48.3×
FY 2016 5y median -82.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31